Associate Dir, Health Systems, Medical Outcomes Science Liaison (North Central)

United States Overview The Health System Medical Outcomes Science Liaison (HS MOSL) is a field-based scientific expert who serves as Alnylam's primary medical liaison within integrated delivery networks (IDNs), academic health systems, and organized healthcare entities. The HS MOSL engages formulary decision makers, C-suite healthcare leaders, clinical pharmacists, and broader clinical leaders who influence formulary and access decisions - providing balanced, evidence-based scientific and health economic information that supports informed formulary, access, and clinical pathway decisions while identifying collaborative research opportunities that advance evidence generation. Territory includes: ND, SD, MN, MI, IN, IL, KY, MO, IA, KS, NE Key Responsibilities Engage and build peer-level relationships with formulary decision makers, C-suite healthcare leaders, clinical pharmacists, pharmacy directors, and key clinical leaders who influence formulary decisions within IDNs and health systems. Conduct balanced, evidence-based scientific exchange to address data needs, gather insights, and communicate the clinical and economic value of Alnylam's portfolio. In collaboration with the Health System Director (HSD), develop account-specific strategic plans including a detailed assessment of key influencers and decision makers. Collect and share evidence gaps and insights to inform Alnylam's Value, Evidence, and Strategy (VESt) Team and advance meaningful data generation. Engage health system stakeholders in evidence-based scientific and outcomes-focused dialogue, drawing on relevant clinical and health economic data to support awareness of diagnostic and treatment considerations across the disease area at the system level. Identify scientific research collaboration opportunities including real-world evidence generation by leveraging internal stakeholders (Medical Affairs, Value & Access, VESt). Provide HEOR and outcomes data to support formulary review processes, clinical pathway development, and health system value assessments. Support regional and national IDN/healthcare systems congresses as needed. Collaborate closely with MSL colleagues to ensure integrated territory-level scientific strategy across clinical and system-level stakeholders. Maintain a thorough understanding of compliance requirements and applicable PhRMA Codes, OIG guidelines, FDA laws, and Alnylam's policies. Apply business acumen to prioritize health system engagements that maximize scientific impact and access for patients. Independently and proactively applies strategic thinking, scientific expertise, engagement excellence, integrity-driven conduct, and cross-functional collaboration within the health system driving strong execution and continuous improvement across access stakeholder engagement. Qualifications Required: Advanced degree - MD, DO, PharmD, or PhD in a relevant life science discipline. HEOR fellowship, MS, MBA, or MPH is a plus. 5+ years of Medical Affairs experience in pharmaceutical or biotech; prior field-based experience working directly with health systems or IDNs strongly preferred. Experience with federal health systems (VA, DoD) is a plus. Demonstrated understanding of pharmacoeconomic and health outcomes research principles. Solid working knowledge of US healthcare ecosystems, IDN structure, and formulary decision-making processes. Strong therapeutic area knowledge; rare disease experience preferred. Solid working knowledge of regulatory and compliance environment including PhRMA, OIG, and FDA guidelines. Excellent written and verbal communication skills; ability to engage diverse audiences from clinical staff to C-suite system leaders. Ability to travel up to 75%; must reside within assigned territory. Valid driver's license required. About Alnylam We are the leader in RNAi therapeutics- a revolutionaryapproach with the potential to transform the lives of people with rare and common diseases. Built on Nobel Prize-winning science, Alnylam has delivered the breakthroughs that made RNAi therapeutics possibleand are just at the beginning of what's possible. Our deep pipeline, late-stage programs, and bold vision reflect our core values: fierce innovation, passion for excellence, purposeful urgency, open culture and commitment to people. We're proud to be a globally recognized top employer, wherean authentic, inclusive culture and breakthrough thinkingfuel one another. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. Qualified applicants will receive consideration for employment without regard to their sex, gender or gender identity, sexual orientation, race, color, ethnicity, national origin, ancestry, citizenship, religion, creed, physical or mental disability, pregnancy status or related conditions, genetic information, veteran or military status, marital or familial status, political affiliation, age, or any other factor protected by federal, state, or local law. Alnylam is an E-Verify Employer. The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity). Alnylam's robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together. #J-18808-Ljbffr Alnylam Pharmaceuticals, Inc.